Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin. (Q44183117)
Jump to navigation
Jump to search
scientific article published in October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin. |
scientific article published in October 2002 |
Statements
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin (English)
Ramadevi Nimmanapalli
Erica O'Bryan
Mei Huang
Purva Bali
Pearlie Kay Burnette
Thomas Loughran
James Tepperberg
Richard Jove
Kapil Bhalla
1 October 2002